This compound is a pharmaceutical intermediate used in the manufacturing process of Avatrombopag. It features a heterocyclic structure with an amine group and a halogen substituent.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 570407-10-2
4-(4-Chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolamine
pharmaceutical intermediate
(R)-(+)-4-(Chloromethyl)-2,2-dimethyl-1,3-dioxolane
pharmaceutical intermediate
(R)-glycidol
pharmaceutical intermediate
(R)-3-Cyclohexenecarboxylic acid
pharmaceutical intermediate
Arotinolol hydrochloride
pharmaceutical raw material
4-(4-chlorothiophen-2-yl)-1,3-thiazol-2-amine
SMBPGSKGPGBYBQ-UHFFFAOYSA-N
C1=C(SC=C1Cl)C2=CSC(=N2)N
—